Efficacy
nausea and vomiting, vomiting, nausea
The incidence of nausea and vomiting in the acute phase, delayed phase and overall phase were separately compared between two treatment group.In the overall phase, the proportions of patients experiencing nausea in prolonged group was 5.97%, while that in the regular group was 12.15% (Percentage of patients experiencing nauseaMultiple-day fosaprepitant regimen was also superior to the regular antiemetic regimen for controlling vomiting in the delayed phase (Fig. Percentage of patients experiencing vomitingIn addition, the incidence of nausea and vomiting beyond delayed phase (120–336 h) was recorded. However, no significant difference was found between two groups (Supplemental Fig. Percentage of patients experiencing AEs